Nitrosamine Impurity Risk Assessment: The 2026 Guide for Pharma Compliance Teams
On July 13, 2018, the FDA recalled valsartan after the probable carcinogen NDMA was … Read more
root causes
On July 13, 2018, the FDA recalled valsartan after the probable carcinogen NDMA was … Read more